Norwegian Heart and Lung Patient Organisation Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
1999
NCT00354081
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1999

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (3)

cyanocobalamin (berocca) (1 trial)

folic acid (1 trial)

pyridoxine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Coronary Artery Disease (Phase 3)

Coronary Disease (Phase 3)

Infarction (Phase 3)

Myocardial Infarction (Phase 3)

Myocardial Ischemia (Phase 3)

Stroke (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 3